Biopsychosocial Factors in Cardiovascular Disease; Psychological and Behavioral Interventions for Cardiovascular Disease; Systematic Reviews and Meta-analysis; Psychometric Testing
M.S., Biostatistics/Patient-Oriented Research, Columbia University, 2012
Postdoctoral Behavioral Cardiology Fellowship, Columbia University, 2009-2012
Ph.D., Child Clinical Psychology, St. John’s University, 2009
Predoctoral Clinical Psychology Internship, Nassau University Medical Center, 2008-2009
M.A., Child Clinical Psychology, St. John’s University, 2007
B.A. (honors), Psychology, New York University, 2004
Dr. Jonathan A. Shaffer serves as a core faculty member in the Clinical Health Psychology doctoral program within the Department of Psychology where he is involved in teaching, mentoring, and research. He is a licensed clinical psychologist with training in cardiovascular behavioral medicine and quantitative methodology. Dr. Shaffer has an active research lab and plans to mentor both undergraduate and graduate students. His research focuses on: (1) the role of biopsychosocial factors in cardiovascular disease and (2) the design and evaluation of psychosocial and behavioral interventions for cardiovascular disease. This research employs novel clinical trial methodology, systematic review and meta-analytic techniques, and prospective cohort study designs.
Dr. Shaffer has conducted and analyzed studies that have examined the prognostic role of and associations among quality of life, depression, posttraumatic stress disorder, and physical activity in patients with acute coronary syndromes and heart failure. He has also pursued clinical work with cardiac patients; completed research on outcomes assessment for behavioral interventions; and studied psychosocial and medical factors that affect older adults with cardiovascular disease.
Dr. Shaffer holds a K23 Career Development Award to conduct a dose-finding study and randomized controlled trial of telephone-delivered Problem-Solving Therapy to improve quality of life in outpatients with heart failure. He has received additional funding from the American Heart Association, and has served as co-investigator/collaborator on grants from the Patient-Centered Outcomes Research Institute.
Dr. Shaffer encourages applicants to the Clinical Health Psychology doctoral program who are interested in working with his lab to apply for Fall 2016.
Shaffer JA, Maurer MS. Multiple chronic conditions and heart failure: Overlooking the obvious? J Am Coll Cardiol 2015; In Press.
Shaffer JA, Thompson JLP, Cheng B, Ye S, Lip GYH, Mann DL, Sacco RL, Pullicino PM, Freudenberger RS, Graham S, Mohr JP, Labovitz AJ, Estol CJ, Lok DJ, Ponikowski P, Anker SD, Di Tullio MR, Homma S, for the WARECEF Investigators. Association of quality of life with anticoagulant control in patients with heart failure: The Warfarin and Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) trial. Int J Cardiol, 2014; 177:715-717.
Voils CI, King H, Maciejewski ML, Allen KD, Yancy WS, Shaffer JA. Approaches for informing optimal dose of behavioral interventions. Ann Behav Med 2014, Apr 11 [Epub ahead of print].
Ye S, Shaffer JA, Rieckmann N, Schwartz JE, Kronish IM, Ladapo JA, Whang W, Burg MM, Davidson KW. Long-term outcomes of enhanced depression treatment in patients with acute coronary syndromes. Am J Med 2014, May 14 [Epub ahead of print]. NIHMSID: NIHMS598535
Shaffer JA, Edmondson D, Wasson LT, Falzon L, Homma K, Ezeokoli N, Li P, Davidson KW. Vitamin D supplementation for depressive symptoms: A systematic review and meta-analysis of randomized controlled trials. Psychosom Med 2014; 76: 190-196. PMCID: PMC4008710
Shaffer JA, Kronish IM, Burg M, Clemow L. Edmondson D. Association of acute coronary syndrome-induced posttraumatic stress disorder symptoms with self-reported sleep. Ann Behav Med 2013; 46: 349-357. PMCID: PMC3800234
Shaffer JA, Epel E, Kang MS, Ye S, Schwartz JE, Davidson KW, Kirkland S, Honig LS, Shimbo D Depressive symptoms are not associated with leukocyte telomere length: Findings from the Nova Scotia Health Survey (NSHS95), a Population-Based Study. PLoS One 2012; 7(10): e48318. PMCID: PMC3485011
Ladapo JA, Shaffer JA, Fang Y, Ye S, Davidson KW. Cost-effectiveness of enhanced depression care after acute coronary syndrome: Results from the COPES randomized controlled trial. Arch Intern Med 2012; 172: 1682-1684. PMCID: PMC3657548
Shaffer JA, Whang W, Shimbo D, Burg M, Schwartz JE, Davidson KW. Do different depression phenotypes have different risks for recurrent coronary heart disease? Health Psych Rev 2012; 6, 165-179.PMCID: PMC3650680
Shaffer JA, Edmondson D, Chaplin WF, Schwartz JE, Shimbo D, Burg MM, Rieckmann N, Davidson KW. Directionality of the relationship between depressive symptom dimensions and C-reactive protein in patients with acute coronary syndromes. Psychosom Med 2011; 73: 370-377. PMCID: PMC3110525
Health Psychology I